October 25th, 2018- How is Artificial Intelligence Benefiting Biopharma?

Date
8am - 10am
Location
Biocom: McGraw Boardroom- 10996 Torreyana Rd. Suite 200, San Diego, CA 92121

Join us for an interactive discussion about the applications of AI in biopharma to accelerate drug discovery.

Pharmaceutical companies have been demonstrating a real interest in artificial intelligence (AI) applications for various research needs in solving more “traditional” tasks.
This seminar will provide access to experts in AI-related technologies, ways AI can increase accuracy, reproducibility, and scale in pathology, how the AI-based integration of pathology data with data from multiple sources can enhance analysis and the application of AI in target generation, identification of hits, and in the assessment of toxicology-related binding interactions.

Reveal Biosciences is a San Diego-based computational pathology company leveraging artificial intelligence (AI) to enable pathologists to make diagnostic decisions faster, more accurately, and with reproducibility at scale. Reveal is developing a pipeline of AI-based pathology decision support diagnostics to benefit patients. The company also supports drug development by combining traditional histopathology with AI to transform tissue biology into actionable data.

Immuneering’s technologies leverage advanced computational approaches and A.I. platforms to accelerate drug discovery and improve clinical outcomes. For diseases where the target is not known, the Cosiner algorithm identifies offsetting molecular profiles for disease and drug by yielding both a target and potential hits. Once a target is established, the Fluency A.I. algorithm eliminates the need for costly high throughput screens by efficiently modeling and predicting the binding interactions between a target and millions of compounds to identify hits for experimental assessment. Lastly, the Fluency-Tox A.I. algorithm models and projects toxicity-related drug binding interactions and can optimize molecules to be less toxic to humans.

Speakers:
Casey Laris, CTO, Reveal Biosciences
Rebecca Kusto, SVP and Head of R&D, Immuneering Corporation

November 8, 2018- Cyber Security Risk Management for the 21st Century

Date
8am - 10am
Location
Biocom: McGraw Boardroom- 10996 Torreyana Rd. Suite 200, San Diego, CA 92121

Cyber threats are evolving and expanding at an astonishing pace. The attack surface has expanded to every area of modern life. Protecting a business’ critical assets has become of paramount importance; however, just as threats have evolved, so must our approach to managing these risks. Aligning security with business priority can elevate cybersecurity risk management from a technology management headache to a competitive advantage. Learn how to assess your risk, prioritize your remediation strategy, and build a security program that effectively minimizes risk to levels commensurate with your business’ risk appetite.

Speakers:
Sean Walls, Vice President, Eurofins Cyber Security, North America, Inc.
Sem Ponnambalam, President, Xahive

Bios:

Sem Ponnambalam, co-founder and President of xahive, is primarily responsible for global operations including cybersecurity governance, education and regulatory reviews. With 18 plus years’ experience in both private, and public sectors, Sem has been instrumental in building relationships between xahive and US, Canadian and UK clinical research institutions. She has lectured and facilitated introduction to cybersecurity governance workshops and courses for businesses including healthcare institutions, Fortune 500 companies and associations. She has also co-authored articles about the importance of cybersecurity in international medical journals, and drafted a manual on cybersecurity steps to protect small, medium, enterprises and not-for-profits from cyberbreaches. Sem was a panelist at the World Economic Forum in NYC speaking about the importance of cybersecurity, in March 2017. Sem was selected as a delegate and panelist to represent Canada at the G20 Youth Summit in Berlin, in 2017. Sem has a Bachelor of Arts Honors in Political Science: International Relations, and a Master of Arts in Legal Studies, specializing in international law both from Carleton University.

Mr. Walls is currently the Vice President of the Cyber Security division at Eurofins, a multi-billion dollar international QA and standards testing organization. He has over 20 years of experience in cybersecurity and information technology. Sean has held executive leadership positions with several national security consulting and IT integration companies. He has been a strategic advisor to hundreds of fortune 500 and 100 companies over the years and speaks regularly on cybersecurity subjects.